KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Accured Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Twist Bioscience (TWST) Shares Issued (2017 - 2026)

Twist Bioscience has reported Shares Issued over the past 10 years, most recently at $1.8 million for Q1 2026.

Quarterly Shares Issued rose 131.74% to $1.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Mar 2026, down 9.87% year-over-year, with the annual reading at $9.3 million for FY2025, 31.59% up from the prior year.
Shares Issued was $1.8 million for Q1 2026 at Twist Bioscience, up from $300000.0 in the prior quarter.
Over five years, Shares Issued peaked at $266.7 million in Q1 2022 and troughed at -$265.1 million in Q2 2022.
The 5-year median for Shares Issued is $1.3 million (2024), against an average of $16.9 million.
The largest YoY upside for Shares Issued was 8696.6% in 2022 against a maximum downside of 184.21% in 2022.
A 5-year view of Shares Issued shows it stood at $604000.0 in 2022, then soared by 57.45% to $951000.0 in 2023, then soared by 210.2% to $2.9 million in 2024, then plummeted by 89.83% to $300000.0 in 2025, then surged by 496.33% to $1.8 million in 2026.
Per Business Quant, the three most recent readings for TWST's Shares Issued are $1.8 million (Q1 2026), $300000.0 (Q4 2025), and $3.8 million (Q3 2025).